Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

PACS Group (PACS) Competitors

PACS Group logo
$36.82 +0.01 (+0.03%)
Closing price 05/19/2026 03:59 PM Eastern
Extended Trading
$36.49 -0.33 (-0.89%)
As of 05/19/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PACS vs. GH, FMS, BTSG, CELC, and HIMS

Should you buy PACS Group stock or one of its competitors? MarketBeat compares PACS Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PACS Group include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does PACS Group compare to Guardant Health?

Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M13.26-$416.28M-$3.39N/A
PACS Group$5.29B1.10$191.54M$1.5623.60

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -40.10%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-40.10% N/A -26.42%
PACS Group 4.49%26.47%4.36%

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Guardant Health presently has a consensus target price of $129.42, indicating a potential upside of 31.81%. PACS Group has a consensus target price of $48.00, indicating a potential upside of 30.36%. Given Guardant Health's stronger consensus rating and higher possible upside, research analysts plainly believe Guardant Health is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
1 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.86
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, Guardant Health had 5 more articles in the media than PACS Group. MarketBeat recorded 13 mentions for Guardant Health and 8 mentions for PACS Group. Guardant Health's average media sentiment score of 0.53 beat PACS Group's score of 0.39 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Guardant Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.03, meaning that its stock price is 103% less volatile than the broader market.

Summary

Guardant Health and PACS Group tied by winning 8 of the 16 factors compared between the two stocks.

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and PACS Group (NYSE:PACS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
PACS Group 4.49%26.47%4.36%

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, indicating a potential upside of 26.56%. PACS Group has a consensus price target of $48.00, indicating a potential upside of 30.36%. Given PACS Group's stronger consensus rating and higher probable upside, analysts clearly believe PACS Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.56
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, PACS Group has a beta of -0.03, meaning that its stock price is 103% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than PACS Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.56$1.11B$1.9011.64
PACS Group$5.29B1.10$191.54M$1.5623.60

In the previous week, PACS Group had 8 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 8 mentions for PACS Group and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.90 beat PACS Group's score of 0.39 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Overall Sentiment
Fresenius Medical Care AG & Co. KGaA Very Positive
PACS Group Neutral

Summary

PACS Group beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks.

How does PACS Group compare to BrightSpring Health Services?

PACS Group (NYSE:PACS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.

In the previous week, PACS Group had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 8 mentions for PACS Group and 6 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.45 beat PACS Group's score of 0.39 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BrightSpring Health Services
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group has higher earnings, but lower revenue than BrightSpring Health Services. PACS Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.10$191.54M$1.5623.60
BrightSpring Health Services$12.91B0.85$190.67M$1.4140.23

PACS Group currently has a consensus target price of $48.00, indicating a potential upside of 30.36%. BrightSpring Health Services has a consensus target price of $56.29, indicating a potential downside of 0.77%. Given PACS Group's higher possible upside, analysts plainly believe PACS Group is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

PACS Group has a net margin of 4.49% compared to BrightSpring Health Services' net margin of 2.27%. PACS Group's return on equity of 26.47% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
BrightSpring Health Services 2.27%14.63%4.41%

PACS Group has a beta of -0.03, suggesting that its share price is 103% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market.

Summary

BrightSpring Health Services beats PACS Group on 8 of the 15 factors compared between the two stocks.

How does PACS Group compare to Celcuity?

PACS Group (NYSE:PACS) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

63.3% of Celcuity shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

PACS Group has a beta of -0.03, meaning that its share price is 103% less volatile than the broader market. Comparatively, Celcuity has a beta of 0.09, meaning that its share price is 91% less volatile than the broader market.

In the previous week, Celcuity had 8 more articles in the media than PACS Group. MarketBeat recorded 16 mentions for Celcuity and 8 mentions for PACS Group. PACS Group's average media sentiment score of 0.39 beat Celcuity's score of 0.35 indicating that PACS Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Celcuity
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.10$191.54M$1.5623.60
CelcuityN/AN/A-$177.04M-$3.90N/A

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Celcuity N/A -244.61%-50.22%

PACS Group presently has a consensus price target of $48.00, indicating a potential upside of 30.36%. Celcuity has a consensus price target of $149.30, indicating a potential upside of 13.89%. Given PACS Group's higher possible upside, equities research analysts clearly believe PACS Group is more favorable than Celcuity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

PACS Group beats Celcuity on 10 of the 15 factors compared between the two stocks.

How does PACS Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.03, indicating that its stock price is 103% less volatile than the broader market.

In the previous week, Hims & Hers Health had 36 more articles in the media than PACS Group. MarketBeat recorded 44 mentions for Hims & Hers Health and 8 mentions for PACS Group. PACS Group's average media sentiment score of 0.39 beat Hims & Hers Health's score of -0.03 indicating that PACS Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
11 Very Positive mention(s)
4 Positive mention(s)
13 Neutral mention(s)
8 Negative mention(s)
5 Very Negative mention(s)
Neutral
PACS Group
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hims & Hers Health currently has a consensus price target of $29.37, indicating a potential upside of 30.72%. PACS Group has a consensus price target of $48.00, indicating a potential upside of 30.36%. Given Hims & Hers Health's higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.18$128.37M-$0.09N/A
PACS Group$5.29B1.10$191.54M$1.5623.60

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PACS Group has a net margin of 4.49% compared to Hims & Hers Health's net margin of -0.56%. PACS Group's return on equity of 26.47% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
PACS Group 4.49%26.47%4.36%

Summary

PACS Group beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

Get PACS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PACS vs. The Competition

MetricPACS GroupMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$5.83B$8.13B$6.25B$22.83B
Dividend YieldN/A3.12%2.80%4.11%
P/E Ratio23.6020.5520.7929.48
Price / Sales1.1016.32531.2123.83
Price / Cash23.0380.7843.0924.68
Price / Book5.605.499.814.61
Net Income$191.54M$180.93M$3.55B$1.07B
7 Day Performance-10.50%-1.58%-2.12%-1.37%
1 Month Performance2.28%-2.75%-4.14%-2.44%
1 Year Performance249.01%0.08%28.34%21.16%

PACS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PACS
PACS Group
3.8545 of 5 stars
$36.82
+0.0%
$48.00
+30.4%
+245.7%$5.83B$5.29B23.6047,455
GH
Guardant Health
3.3455 of 5 stars
$96.20
-0.5%
$129.42
+34.5%
+144.0%$12.80B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
4.8456 of 5 stars
$22.12
+1.6%
$28.00
+26.6%
-24.0%$12.35B$22.20B11.631,488
BTSG
BrightSpring Health Services
3.2773 of 5 stars
$55.49
+0.8%
$56.29
+1.4%
+135.3%$10.78B$12.91B39.4323,500
CELC
Celcuity
2.2819 of 5 stars
$123.96
-1.3%
$134.50
+8.5%
+1,126.3%$6.01BN/AN/A40

Related Companies and Tools


This page (NYSE:PACS) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners